{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:05:14Z","timestamp":1762459514533,"version":"3.37.3"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/26"],"award-info":[{"award-number":["MC_UU_12023\/26"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/cid\/cix854","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T19:13:27Z","timestamp":1505934807000},"page":"594-603","source":"Crossref","is-referenced-by-count":10,"title":["Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand"],"prefix":"10.1093","volume":"66","author":[{"name":"The European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group in EuroCoord","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intira Jeannie","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luminita","family":"Ene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colette","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Goodall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Judd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Noguera-Julian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Guillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo Rojo","family":"Conejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiane","family":"Warszawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Koenigs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana","family":"Spoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filipa","family":"Prata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa","family":"Goetghebuer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"de Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Gabiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Naver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Marczynska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liubov","family":"Okhonskaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzague","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narong","family":"Lertpienthum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achara","family":"Puangsombat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruslan","family":"Malyuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Volokha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Radoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"volume-title":"Global HIV statistics: fact sheet July 2017","year":"2017","author":"Joint United Nations Programme on HIV\/AIDS","key":"key\n\t\t\t\t20180328134251_CIT0001"},{"key":"key\n\t\t\t\t20180328134251_CIT0002","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1097\/QAD.0000000000000316","article-title":"Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis","volume":"28","author":"Kim","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0003","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South Africa\u2014the IeDEA Southern Africa collaboration","volume":"56","author":"Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328134251_CIT0004","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1001\/jama.2013.3710","article-title":"Association between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children","volume":"309","author":"Lowenthal","year":"2013","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20180328134251_CIT0005","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1097\/QAD.0000000000000438","article-title":"Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland","volume":"28","author":"Duong","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/QAI.0b013e318298a309","article-title":"Five-year trends in antiretroviral usage and drug costs in HIV-infected children in Thailand","volume":"64","author":"Collins","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328134251_CIT0007","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(10)70313-3","article-title":"First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2\/3 trial","volume":"11","author":"Babiker","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180328134251_CIT0008","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(12)62198-9","article-title":"Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial","volume":"381","author":"Kekitiinwa","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328134251_CIT0009","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/S0140-6736(13)61409-9","article-title":"Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial","volume":"382","author":"Cotton","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328134251_CIT0010","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e32834d614c","article-title":"Early antiretroviral therapy in HIV-1-infected infants, 1996\u20132008: treatment response and duration of first-line regimens","volume":"25","author":"Judd","year":"2011","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0011","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1089\/aid.2016.0039","article-title":"Impact of viral load use on treatment switch in perinatally HIV-infected children in Asia","volume":"33","author":"Mohamed","year":"2016","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328134251_CIT0012","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/QAD.0000000000000349","article-title":"Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa","volume":"28","author":"Petersen","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0013","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/QAD.0000000000000707","article-title":"Determinants of durability of first-line antiretroviral therapy regimen and time from first-line failure to second-line antiretroviral therapy initiation","volume":"29","author":"Desmonde","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0014","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.15585\/mmwr.mm6547a2","article-title":"Progress with scale-up of HIV viral load monitoring\u2014seven sub-Saharan African countries, January 2015\u2013June 2016","volume":"65","author":"Lecher","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180328134251_CIT0015","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1468-1293.2009.00759.x","article-title":"PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection","volume":"10","author":"Welch","year":"2009","journal-title":"HIV Med"},{"author":"World Health Organization","key":"key\n\t\t\t\t20180328134251_CIT0016"},{"key":"key\n\t\t\t\t20180328134251_CIT0017","article-title":"Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life","author":"Bamford","year":"2015","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328134251_CIT0018","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"volume-title":"WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children","year":"2007","author":"World Health Organization","key":"key\n\t\t\t\t20180328134251_CIT0019"},{"key":"key\n\t\t\t\t20180328134251_CIT0020","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0b013e32823ecf5b","article-title":"Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART","volume":"21","author":"Chiappini","year":"2007","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0021","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/hiv.12411","article-title":"Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe","volume":"18","author":"Judd","year":"2016","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180328134251_CIT0022","unstructured":"Wools-Kaloustian K , SmithC, GoodallR Predictors of switch to second-line ART in HIV-positive children: a global analysis (poster 815). In: Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2017."},{"key":"key\n\t\t\t\t20180328134251_CIT0023","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/tmi.12656","article-title":"Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges","volume":"21","author":"Ferrand","year":"2016","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20180328134251_CIT0024","doi-asserted-by":"crossref","first-page":"e012934","DOI":"10.1136\/bmjopen-2016-012934","article-title":"Qualitative study of the BREATHER trial (short cycle antiretroviral therapy): is it acceptable to young people living with HIV","volume":"7","author":"Bernays","year":"2017","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180328134251_CIT0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20490","article-title":"BREATHER (PENTA 16) short-cycle therapy (SCT) (5 days on\/2 days off) in young people with chronic human immunodeficiency virus infection: an open, randomised, parallel-group phase II\/III trial","volume":"20","author":"Butler","year":"2016","journal-title":"Health Technol Assess"},{"key":"key\n\t\t\t\t20180328134251_CIT0026","unstructured":"Turkova A , ButlerK, MooreC Long-term effects of weekends off ART in HIV-1 infected young people on EFV + 2 NRTIs (poster 813). In: Conference on Retroviruses and Opportunistic Infections, Seattle, WA, 2017."},{"key":"key\n\t\t\t\t20180328134251_CIT0027","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciw488","article-title":"Nevirapine- versus lopinavir\/ritonavir-based antiretroviral therapy in HIV-infected infants and young children: long-term follow-up of the IMPAACT P1060 randomized trial","volume":"63","author":"Barlow-Mosha","year":"2016","journal-title":"Clin Infect Dis"},{"author":"Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Chlidren","key":"key\n\t\t\t\t20180328134251_CIT0028","article-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection 2012"},{"author":"World Health Organization","key":"key\n\t\t\t\t20180328134251_CIT0029"},{"key":"key\n\t\t\t\t20180328134251_CIT0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/COH.0000000000000378","article-title":"Prioritizing the most needed formulations to accelerate paediatric antiretroviral therapy scale-up","volume":"12","author":"Penazzato","year":"2017","journal-title":"Curr Opin HIV AIDS"},{"key":"key\n\t\t\t\t20180328134251_CIT0031","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/QAI.0000000000000671","article-title":"HIV-1 drug resistance and second-line treatment in children randomized to switch at low versus higher RNA thresholds","volume":"70","author":"Harrison","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328134251_CIT0032","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/jac\/dkw218","article-title":"Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa","volume":"71","author":"Boender","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328134251_CIT0033","doi-asserted-by":"crossref","first-page":"e0161469","DOI":"10.1371\/journal.pone.0161469","article-title":"Marginal structural models to assess delays in second-line HIV treatment initiation in South Africa","volume":"11","author":"Rohr","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328134251_CIT0034","doi-asserted-by":"crossref","first-page":"ofw018","DOI":"10.1093\/ofid\/ofw018","article-title":"The effect of switching to second-line antiretroviral therapy on the risk of opportunistic infections among patients infected with human immunodeficiency virus in northern Tanzania","volume":"3","author":"Ramadhani","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180328134251_CIT0035","doi-asserted-by":"crossref","first-page":"e49591","DOI":"10.1371\/journal.pone.0049591","article-title":"Pediatric response to second-line antiretroviral therapy in South Africa","volume":"7","author":"Zanoni","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328134251_CIT0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/aid.2012.0283","article-title":"Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1\u2013infected Ugandan children","volume":"29","author":"Musiime","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20180328134251_CIT0037","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/QAI.0000000000000971","article-title":"Treatment outcomes and resistance patterns of children and adolescents on second-line antiretroviral therapy in Asia","volume":"72","author":"Prasitsuebsai","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20180328134251_CIT0038","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/INF.0000000000000848","article-title":"Safety, pharmacokinetics and efficacy of dolutegravir in treatment-experienced HIV-1 infected adolescents: forty-eight-week results from IMPAACT P1093","volume":"34","author":"Viani","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180328134251_CIT0039","unstructured":"Ruel T , AcostaE, SinghT Dolutegravir pharmacokinetics, safety and efficacy in HIV+ children 2 to <6 years old (poster 806). In: Conference on Retroviruses and Opportunistic Infections, Boston, MA, 2016."}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/4\/594\/24020876\/cix854.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T03:26:35Z","timestamp":1659497195000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/66\/4\/594\/4237699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,9,26]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix854","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2018,2,15]]},"published":{"date-parts":[[2017,9,26]]}}}